Regeneron Pharmaceuticals Inc (REGN)
Debt-to-assets ratio
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 40,169,400 | 38,219,200 | 37,545,200 | 37,759,400 | 37,441,900 | 36,086,800 | 34,369,600 | 33,080,200 | 32,163,300 | 30,657,500 | 30,059,900 | 29,214,500 | 27,677,800 | 27,205,800 | 26,348,700 | 25,434,800 | 23,671,500 | 21,485,900 | 17,772,200 | 17,163,300 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
September 30, 2025 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $40,169,400K
= 0.00
Peer comparison
Sep 30, 2025
Company name
Symbol
Debt-to-assets ratio
Regeneron Pharmaceuticals Inc
REGN
0.00
Arrowhead Pharmaceuticals Inc
ARWR
0.00
Biomarin Pharmaceutical Inc
BMRN
0.00
See also:
Regeneron Pharmaceuticals Inc Debt to Assets (Quarterly Data)